Du, Luping
Sun, Xiaotong
Gong, Hui
Wang, Ting
Jiang, Liujun
Huang, Chengchen
Xu, Xiaodong
Li, Zhoubin
Xu, Hongfei
Ma, Liang
Li, Weidong
Chen, Ting
Xu, Qingbo http://orcid.org/0000-0003-2474-8155
Funding for this research was provided by:
National Natural Science Foundation of China (82030008, 31830039, 81770435)
Article History
Received: 12 July 2022
Accepted: 13 February 2023
First Online: 20 February 2023
Declarations
:
: All animal experiments and protocols were performed in accordance with the National Institutes of Health’s Guide for the Care and Use of Laboratory. The animal studies were approved by the Research Ethics Committees of the First Affiliated Hospital of Zhejiang University (Title, The role of CD34 positive cells and the mechanism of differentiation in myocardial fibrosis; The Tab of Animal Experimental Ethical Inspection of the First Affiliated Hospital, Zhejiang University School of Medicine; Approval Reference No. 2021/159; Date, February 4, 2021). All animal experiments were conducted according to the ARRIVE guidelines. As for the human heart samples, the study protocol was approved by the Research Ethics Committees of the First Affiliated Hospital of Zhejiang University (Title, Stem cells in cardiovascular diseases and exploring novel mechanisms; Clinical Research Ethics Committees of the First Affiliated Hospital, College of medicine, Zhejiang; Approval Reference No. 2021/330; Date, May 10, 2021), and written informed consent was obtained from all patients, which clearly stated the purpose of our study.
: Not applicable.
: The authors declared no potential conflicts of interest.